Game Plan Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Game Plan Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.16K	Hold	34	–	–	﹤0.01%	262
2026 Q2	$6.47K	Hold	34	–	–	﹤0.01%	255
2026 Q1	$5.74K	Hold	34	–	–	﹤0.01%	230
2025 Q4	$5.74K	Hold	34	–	–	﹤0.01%	234
2025 Q3	$4.91K	Sell	34 -20	-37%	-$2.73K	﹤0.01%	248
2025 Q2	$6.83K	Hold	54	–	–	﹤0.01%	238
2025 Q1	$6.91K	Hold	54	–	–	﹤0.01%	237
2024 Q4	$7.12K	Hold	54	–	–	﹤0.01%	243
2024 Q3	$7.86K	Hold	54	–	–	﹤0.01%	247
2024 Q2	$7.41K	Hold	54	–	–	﹤0.01%	251
2024 Q1	$7.41K	Hold	54	–	–	﹤0.01%	285
2023 Q4	$7.34K	Buy	+54	New	+$6.59K	﹤0.01%	269

Other funds holding IBB

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Game Plan Financial Advisors's IBB Position: Q3 2026 in Review

Game Plan Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 34 shares worth $7.16K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Game Plan Financial Advisors first reported a position in IBB in Q4 2023 and has held it in 12 quarters since. The position peaked at $7.86K in Q3 2024. 700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Game Plan Financial Advisors held 34 shares of iShares Biotechnology ETF worth $7.16K as of Q3 2026.
Game Plan Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q3 2026.
iShares Biotechnology ETF made up ﹤0.01% of Game Plan Financial Advisors's portfolio in Q3 2026, its #262 holding.
Game Plan Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 12 quarters since.
Game Plan Financial Advisors's iShares Biotechnology ETF position peaked at $7.86K in Q3 2024.
700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Game Plan Financial Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.